- Home
- ACHV vs AMTX Comparison
ACHV vs AMTX Comparison
Compare ACHV & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- AMTX
- Stock Information
- Founded
- ACHV N/A
- AMTX 2005
- Country
- ACHV Canada
- AMTX United States
- Employees
- ACHV N/A
- AMTX N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AMTX Major Chemicals
- Sector
- ACHV Health Care
- AMTX Industrials
- Exchange
- ACHV Nasdaq
- AMTX Nasdaq
- Market Cap
- ACHV 92.6M
- AMTX 108.1M
- IPO Year
- ACHV N/A
- AMTX N/A
- Fundamental
- Price
- ACHV $2.70
- AMTX $1.75
- Analyst Decision
- ACHV Strong Buy
- AMTX Strong Buy
- Analyst Count
- ACHV 4
- AMTX 4
- Target Price
- ACHV $15.75
- AMTX $14.56
- AVG Volume (30 Days)
- ACHV 162.2K
- AMTX 839.2K
- Earning Date
- ACHV 03-11-2025
- AMTX 03-14-2025
- Dividend Yield
- ACHV N/A
- AMTX N/A
- EPS Growth
- ACHV N/A
- AMTX N/A
- EPS
- ACHV N/A
- AMTX N/A
- Revenue
- ACHV N/A
- AMTX $267,640,000.00
- Revenue This Year
- ACHV N/A
- AMTX $57.42
- Revenue Next Year
- ACHV N/A
- AMTX $63.37
- P/E Ratio
- ACHV N/A
- AMTX N/A
- Revenue Growth
- ACHV N/A
- AMTX 43.34
- 52 Week Low
- ACHV $2.51
- AMTX $1.50
- 52 Week High
- ACHV $5.59
- AMTX $6.14
- Technical
- Relative Strength Index (RSI)
- ACHV 41.28
- AMTX 42.12
- Support Level
- ACHV $2.70
- AMTX $1.81
- Resistance Level
- ACHV $2.99
- AMTX $2.03
- Average True Range (ATR)
- ACHV 0.20
- AMTX 0.17
- MACD
- ACHV 0.01
- AMTX 0.01
- Stochastic Oscillator
- ACHV 34.55
- AMTX 40.77
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.